A Summary of the Rare Reports of Osteonecrosis of the Jaw Associated With Tumor Necrosis-α Inhibitors in the United States Food and Drug Administration's Adverse Event Reporting System Database
- 1 July 2023
- journal article
- research article
- Published by Elsevier in Journal of Oral and Maxillofacial Surgery
- Vol. 81 (10) , 1311-1318
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Pathophysiology of Osteonecrosis of the JawsOral and Maxillofacial Surgery Clinics of North America, 2015
- Osteonecrosis of the Jaw in the United States Food and Drug Administration's Adverse Event Reporting System (FAERS)Journal of Bone and Mineral Research, 2015
- Osteonecrosis of the jaw in a Crohn’s disease patient following a course of Bisphosphonate and Adalimumab therapy: a case reportBMC Gastroenterology, 2014
- Oral Health Risk Factors for Bisphosphonate-Associated Jaw OsteonecrosisJournal of Oral and Maxillofacial Surgery, 2013
- Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastasesAnnals of Oncology, 2011
- Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with special emphasis on risks in the elderlyRheumatology, 2010
- Tumor necrosis factor antagonist mechanisms of action: A comprehensive reviewPharmacology & Therapeutics, 2008
- TNF.ALPHA. and pathologic bone resorptionThe Keio Journal of Medicine, 2005
- Tumor Necrosis Factor-α Regulates Expression of Vascular Endothelial Growth Factor Receptor-2 and of Its Co-receptor Neuropilin-1 in Human Vascular Endothelial CellsJournal of Biological Chemistry, 1998
- A method for estimating the probability of adverse drug reactionsClinical Pharmacology & Therapeutics, 1981